Simplified Process

90% of investors who trade in the stock market lose money. We researched top traders for months who were consistently making recommendations across various networks and raving across how these securities were going to keep increasing in value. These notifications however, were always followed by a massive decline in price resulting is stock chasers holding overweight positions at a loss. We came to the conclusion that manipulation runs deep across the market and it's impossible to time the parabolic stocks on the upside.. 

What we did realize is that you might not catch the ride up, but with the right indicators and strategy, you can always benefit from the downside price movement by shorting. Over 3 months, we recorded every NYSE / NASDAQ / CBOE security which performed parabolic movements and found that a significant correction occurred in 98% of instances, usually resulting in the price adjustment of 28% of more. For those 2% of instances a short squeeze would occur (stock keeps increasing in value due to excessive short interest), so we identified a process for easily identifying these isolated instances.

Proven Strategies

Our algorithm had performed rigorous back-testing prior to launching to confirm statistically consistent results across various securities and trading strategies.

Step-by-Step Guide

Combining the indicators from the algorithm with our easy to follow trading strategies, traders can now improve their overall trading performance.

Trading Videos

Shorting NBY on 2021_01_13
(Novabay Pharmaceuticals)

Shorting LIVE on 2021_01_13
(Live Ventures Inc)

Shorting NXTD on 2020_12_16
(NXTD-ID, Inc)

Shorting NVCN on 2020_12_16
(Neovasc, Inc)

Shorting XXII on 2020_12_14
(22nd Century Group)

Shorting ARVN on 2020_12_14
(Arvinas, Inc)

Shorting GENE on 2020_12_10
(Genetic Technologies)

Shorting ANIX on 2020_12_10
(Anixa Biosciences)

Shorting ACOR on 2021_01_13
(Acorda Therapeutics, Inc.)

Shorting CCM on 2020_12_16
(Concord Medical Services, Ltd)

Shorting RUBY on 2020_12_14
(Rubius Therapeutics, Inc)

Shorting RCON on 2020_12_10
(Recon Technology)

ShortAlgo is not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction and we are not qualified to give financial advice. Trading in financial securities is highly speculative and carries an extremely high degree of risk.


App Store.png
  • Reddit
  • Twitter
  • YouTube

© 2021 ShortAlgo, Part of MarketingFox Solutions